Cargando…
Extracellular Vesicles Derived from Mesenchymal Stem Cells: A Potential Biodrug for Acute Respiratory Distress Syndrome Treatment
Acute respiratory distress syndrome (ARDS) is a severe respiratory disease associated with high morbidity and mortality in the clinic. In the face of limited treatment options for ARDS, extracellular vesicles derived from mesenchymal stem cells (MSC-EVs) have recently shown promise. They regulate le...
Autores principales: | Sun, Hao, Zhang, Tianyuan, Gao, Jianqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463673/ https://www.ncbi.nlm.nih.gov/pubmed/36087245 http://dx.doi.org/10.1007/s40259-022-00555-5 |
Ejemplares similares
-
Mesenchymal stem cell‐derived extracellular vesicles for the treatment of acute respiratory distress syndrome
por: Abraham, Aswin, et al.
Publicado: (2019) -
Mesenchymal stem cells-derived extracellular vesicles in acute respiratory distress syndrome: a review of current literature and potential future treatment options
por: Shah, Trushil G., et al.
Publicado: (2019) -
Advances of mesenchymal stem cells and their derived extracellular vesicles as a promising therapy for acute respiratory distress syndrome: from bench to clinic
por: Zhuang, Xiaoli, et al.
Publicado: (2023) -
Pharmacological Functions, Synthesis, and Delivery Progress for Collagen as Biodrug and Biomaterial
por: Zhou, Nan, et al.
Publicado: (2023) -
Effects of mesenchymal stromal cell-derived extracellular vesicles in acute respiratory distress syndrome (ARDS): Current understanding and future perspectives
por: Su, Yue, et al.
Publicado: (2021)